Role of fragile sites FATS and FMR1 in tumor progression and their potential clinical significance
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35417 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Chuangdong Ruan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital, Guangdong Pharmaceutical University, Guangzhou, China. Hauptthemen laut MEDLINE: Neoplasms, Chromosome Fragile Sites, Fragile X Messenger Ribonucleoprotein 1. Die Arbeit nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Medical Research Foundation, Project in Key Areas of Guangdong Province's General Colleges and Universities.
Abstract (Originalsprache)
The fragile sites are defined as specific segments of genes that are particularly susceptible to breakage under conditions of accelerated replication stress or certain external influences. It has been demonstrated that fragile sites can influence the progression of various tumors. However, the majority of existing studies have focused on the functions of well‐characterized common fragile sites, such as FHIT , WWOX , and PARK2 , in different oncogenic processes, with insufficient attention directed towards other fragile sites. This article presents an analysis of recent investigations into the fragile sites, fragile site‐associated tumor suppressor ( FATS ) and fragile X mental retardation 1 ( FMR1 ), across various tumor types. The article discusses the mechanisms and signaling pathways regulated by these sites in a range of cancers, as well as their clinical implications for tumor treatment. The review highlights the significance of the fragile sites FATS and FMR1 in various cancers and their clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital, Guangdong Pharmaceutical University, Guangzhou, China.
- School of Life Sciences and Biopharmaceutics, Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Guangdong Pharmaceutical Univ…
- The Second Clinical Medical School of Guangdong Pharmaceutical University(Guangdong Second Provincial General Hospital), Guangzhou, China.
ORCID-Profile: Yan Li
Förderung
- National Natural Science Foundation of China
- Guangdong Medical Research Foundation
- Project in Key Areas of Guangdong Province's General Colleges and Universities
Zitieren
APA
Ruan, C., Xie, Y., Ye, H., Zhang, Y., Zhang, R., & Li, Y. (2025). Role of fragile sites FATS and FMR1 in tumor progression and their potential clinical significance. International Journal of Cancer. https://doi.org/10.1002/ijc.35417
Vancouver
Ruan C, Xie Y, Ye H, Zhang Y, Zhang R, Li Y. Role of fragile sites FATS and FMR1 in tumor progression and their potential clinical significance. International Journal of Cancer. 2025. doi:10.1002/ijc.35417
BibTeX
@article{Ruan2025,
author = {Ruan, Chuangdong and Xie, Yichun and Ye, Huabin and Zhang, Yuqin and Zhang, Rongxin and Li, Yan},
title = {Role of fragile sites FATS and FMR1 in tumor progression and their potential clinical significance},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35417}
}
EUVIMED